The effect of fluvastatin on cICAM-1 as a biomarker of endothelial dysfunction in patients with dyslipidemia

International Angiology

Volumn 25, Issue 4, 2006, Pages 414-417

  Šejda, Tomas ^a   Jedliekova V ^a   Svandova E ^b   Poledne, R ^c  

^a FAKULTNÍ THOMAYEROVA NEMOCNICE   (Czech Republic)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (Czech Republic)

^c INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

Atherosclerosis; Endothelium; Fluvastatin; Intercellular adhesion molecule 1

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; FLUINDOSTATIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERCELLULAR ADHESION MOLECULE 1; LESCOL XL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; DIASTOLIC BLOOD PRESSURE; DRUG MECHANISM; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; LIPOPROTEIN BLOOD LEVEL; MALE; PATIENT COMPLIANCE; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION;

BIOLOGICAL MARKERS; DYSLIPIDEMIAS; ENDOTHELIUM, VASCULAR; FATTY ACIDS, MONOUNSATURATED; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INDOLES; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED;

EID: 33847680423     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Stenvinkel P. Endothelial dysfunction and inflammation: is there a link? Nephrol Dial Transplant 2001;16:1968-71.
2. Šejda T, Kovář J, Pit'ha J, Cífková R, Švandová E, Poledne R. The effect of an acute fat load on endothelial function after different dietary regimens in young healthy volunteers. Physiol Res 2002;51:99-105.
3. Vogel A, Correti C, Gellman J. Cholesterol, cholesterol lowering and endothelial function. Prog Cardiovasc Dis 1998;41:117-36.
4. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-9.
5. Dong ZM, Wagner DD. Leukocyte-endothelium adhesion molecules in atherosclerosis. J Lab Clin Med 1998;132:369-75.
6. Smalley DM, Lin JH, Curtis ML, Kobari Y, Stemerman MB, Pritchard KAJ. Native LDL increases endothelial cell adhesiveness by inducing intercellular adhesion molecule-1. Arterioscler Thromb Vasc Biol 1996;16:585-90.
7. Davies MJ, Gordon JL, Gearing AJ, Pigott R, Wooff N, Katz D et al. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J Pathol 1993;171:223-9.
8. Jilma B, Joukhadar CH, Derhasching U, Rassoul F, Richter V, Woltz M et al. Levels of adhesion molecules do not decrease after 3 months of statin therapy in moderate hypercholesterolaemia. Clin Sci (Lond) 2003;104:189-93.
9. Sampietro T, Tuoni M, Ferdeghini M, Ciardia A, Marracini P, Prontera C et al. Plasma cholesterol regulates soluble cell adhesion molecules expression in familial hypercholesterolemia. Circulation 1997;96:1381-5.
10. Romano M, Mezzeti A, Marulli C, Ciabattoni G, Febo F, Di Ienno S et al. Fluvastatin reduces soluble P-selektin and ICAM-1 levels in hypercholesterolemic patients: role of nitric oxide. J Investig Med 2000;48:183-9.
11. 2- and ICAM-1 levels in a rat model with aortic remodeling induced by pressure overload. Am J Physiol Heart Circ Physiol 2001;281:H655-H660.
12. O'Brien KD, McDonald TO, Chait A, Allen MD, Alpers CE. Neovascular expression of E-selectin, intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation 1996;93:672-82.
13. Šejda T, Pit'ha J, Švandová E, Poledne R. Limitation of non-invasive endothelial function assessment by brachial artery flow-mediated dilatation. Clin Physiol Funct Imaging 2005; 25:58-61.
14. Hackman A, Abe Y, Insull W, Pownall H, Smith L, Dunn K et al. Levels of soluble cell adhesion molecules in patients with dyslipidemia. Circulation 1996;93:1334-8.
15. Blann AD, Gurney D, Hughes E, Buggins P, Silverman SH, Lip GY: Influence of pravastatin on lipoproteins, and on endothelial, platelet and inflammatory markers in subject with peripheral artery disease. Am J Cardiol 2001;88:89-92.
16. Ridker PM, Hennekens CH, Roitman-Johnson B, Stampfer MJ, Allen J. Plasma concentration of soluble intercellular adhesion molecule 1 and risk of future myocardial infarction in apparently healthy men. Lancet 1998;351:88-92.